Zailing Xing, Douglas D. Schocken, Janice C. Zgibor, Amy C. Alman
{"title":"非糖尿病患者胰岛素抵抗、心力衰竭事件和全因死亡率的过程和轨迹","authors":"Zailing Xing, Douglas D. Schocken, Janice C. Zgibor, Amy C. Alman","doi":"10.1007/s12020-024-04037-2","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>In nondiabetic people, the long-term effects of insulin resistance (IR) on heart failure (HF) and all-cause mortality have not been studied.</p><h3 data-test=\"abstract-sub-heading\">Objectives</h3><p>To examine the association between IR trajectories and incident HF and all-cause mortality in a nondiabetic population.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>We studied 7835 nondiabetic participants from the Atherosclerosis Risk in Communities (ARIC) Study. We estimated IR with several methods: Homeostatic Model Assessment-Insulin Resistance (HOMA-IR), triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C), triglyceride glucose Index (TyG Index), and metabolic score for insulin resistance (METS-IR). The latent class analysis identified two trajectories for HOMA-IR (‘low level’ and ‘high level’), and three trajectories for TG/HDL-C, TyG index, and METS-IR (‘low level’, ‘moderate level’, and ‘high level’). Cox proportional hazard models were employed to examine the association.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Participants in the ‘high level’ group of HOMA-IR trajectory patterns were more likely to have incident HF and all-cause mortality with HRs (95% CIs) of 1.29 (1.11–1.50) and 1.31(1.19–1.44), respectively, compared to the ‘low level’ group. Similarly, participants in the ‘moderate level’ and ‘high level’ groups of TG/HDL-C, TyG index, and METS-IR trajectories had elevated risks of incident HF and all-cause mortality. However, no increased risk was found for all-cause mortality for men in the ‘moderate level’ and ‘high level’ group of TG/HDL-C, TyG index, and METS-IR relative to the ‘low level’ group.</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>Long-term moderate and high IR levels were positively associated with increased risks of incident HF for both males and females. For all-cause mortality, however, consistent associations were found only in women.</p><h3 data-test=\"abstract-sub-heading\">Graphical Abstract</h3>","PeriodicalId":11572,"journal":{"name":"Endocrine","volume":"20 1","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Course and trajectories of insulin resistance, incident heart failure and all-cause mortality in nondiabetic people\",\"authors\":\"Zailing Xing, Douglas D. Schocken, Janice C. Zgibor, Amy C. Alman\",\"doi\":\"10.1007/s12020-024-04037-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h3 data-test=\\\"abstract-sub-heading\\\">Background</h3><p>In nondiabetic people, the long-term effects of insulin resistance (IR) on heart failure (HF) and all-cause mortality have not been studied.</p><h3 data-test=\\\"abstract-sub-heading\\\">Objectives</h3><p>To examine the association between IR trajectories and incident HF and all-cause mortality in a nondiabetic population.</p><h3 data-test=\\\"abstract-sub-heading\\\">Methods</h3><p>We studied 7835 nondiabetic participants from the Atherosclerosis Risk in Communities (ARIC) Study. We estimated IR with several methods: Homeostatic Model Assessment-Insulin Resistance (HOMA-IR), triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C), triglyceride glucose Index (TyG Index), and metabolic score for insulin resistance (METS-IR). The latent class analysis identified two trajectories for HOMA-IR (‘low level’ and ‘high level’), and three trajectories for TG/HDL-C, TyG index, and METS-IR (‘low level’, ‘moderate level’, and ‘high level’). Cox proportional hazard models were employed to examine the association.</p><h3 data-test=\\\"abstract-sub-heading\\\">Results</h3><p>Participants in the ‘high level’ group of HOMA-IR trajectory patterns were more likely to have incident HF and all-cause mortality with HRs (95% CIs) of 1.29 (1.11–1.50) and 1.31(1.19–1.44), respectively, compared to the ‘low level’ group. Similarly, participants in the ‘moderate level’ and ‘high level’ groups of TG/HDL-C, TyG index, and METS-IR trajectories had elevated risks of incident HF and all-cause mortality. However, no increased risk was found for all-cause mortality for men in the ‘moderate level’ and ‘high level’ group of TG/HDL-C, TyG index, and METS-IR relative to the ‘low level’ group.</p><h3 data-test=\\\"abstract-sub-heading\\\">Conclusions</h3><p>Long-term moderate and high IR levels were positively associated with increased risks of incident HF for both males and females. For all-cause mortality, however, consistent associations were found only in women.</p><h3 data-test=\\\"abstract-sub-heading\\\">Graphical Abstract</h3>\",\"PeriodicalId\":11572,\"journal\":{\"name\":\"Endocrine\",\"volume\":\"20 1\",\"pages\":\"\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2024-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endocrine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12020-024-04037-2\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12020-024-04037-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
Course and trajectories of insulin resistance, incident heart failure and all-cause mortality in nondiabetic people
Background
In nondiabetic people, the long-term effects of insulin resistance (IR) on heart failure (HF) and all-cause mortality have not been studied.
Objectives
To examine the association between IR trajectories and incident HF and all-cause mortality in a nondiabetic population.
Methods
We studied 7835 nondiabetic participants from the Atherosclerosis Risk in Communities (ARIC) Study. We estimated IR with several methods: Homeostatic Model Assessment-Insulin Resistance (HOMA-IR), triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C), triglyceride glucose Index (TyG Index), and metabolic score for insulin resistance (METS-IR). The latent class analysis identified two trajectories for HOMA-IR (‘low level’ and ‘high level’), and three trajectories for TG/HDL-C, TyG index, and METS-IR (‘low level’, ‘moderate level’, and ‘high level’). Cox proportional hazard models were employed to examine the association.
Results
Participants in the ‘high level’ group of HOMA-IR trajectory patterns were more likely to have incident HF and all-cause mortality with HRs (95% CIs) of 1.29 (1.11–1.50) and 1.31(1.19–1.44), respectively, compared to the ‘low level’ group. Similarly, participants in the ‘moderate level’ and ‘high level’ groups of TG/HDL-C, TyG index, and METS-IR trajectories had elevated risks of incident HF and all-cause mortality. However, no increased risk was found for all-cause mortality for men in the ‘moderate level’ and ‘high level’ group of TG/HDL-C, TyG index, and METS-IR relative to the ‘low level’ group.
Conclusions
Long-term moderate and high IR levels were positively associated with increased risks of incident HF for both males and females. For all-cause mortality, however, consistent associations were found only in women.
期刊介绍:
Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology.
Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted.
Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.